PFE 📈 Pfizer - Overview

Pfizer Inc. operates as a multinational biopharmaceutical company, engaging in the discovery, development, manufacturing, marketing, distribution, and sale of a wide range of biopharmaceutical products globally. The company's product portfolio encompasses various therapeutic areas, including cardiovascular metabolic, migraine, and women's health, where it offers established brands such as Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family. Additionally, Pfizer addresses infectious diseases with significant unmet medical needs through brands like the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba, alongside its efforts in COVID-19 prevention and treatment with Comirnaty and Paxlovid.

The company further diversifies its offerings with medicines and vaccines in areas such as biosimilars for chronic immune and inflammatory diseases, where it utilizes brands like Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo. It also targets specific conditions including amyloidosis, hemophilia, endocrine diseases, and sickle cell disease with brands such as the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin. Moreover, Pfizer provides sterile injectable and anti-infective medicines under brands like Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga, as well as a range of biologics, small molecules, immunotherapies, and biosimilars including Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi.

Pfizer's business model extends to contract manufacturing, catering to a broad customer base that includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has established strategic collaboration agreements with several industry peers, including Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Merck KGaA, and BioNTech SE. Furthermore, Pfizer has entered into a strategic clinical collaboration with Acepodia Inc. aimed at developing antibody-cell conjugation-based cell therapies for autoimmune diseases, underscoring its commitment to innovation and addressing unmet medical needs. Founded in 1849, Pfizer Inc. is headquartered in New York, New York, and its common stock is listed under the ISIN US7170811035, classified within the Pharmaceuticals sub-industry.